Global Bovine Respiratory Disease Treatment Market: Overview
Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and environmental factors. The major factor leading to bovine respiratory diseases are host factors, environmental factors, and direct influence of infectious agents such as virus, bacteria, and parasites. However, due to increasing consumption of milk and beef products, the need for bovine respiratory disease treatment has increased across the globe.
Moreover, according to the World Bank Group (2016), global human population is estimated to be 7.4 billion in 2016 and is growing at a rate of 1.8% per year. Hence, demand for beef has increased due to rising population and increasing disposable income across the world. The rising demand for high quality bovine derived products is influencing the bovine respiratory disease treatment market. Despite of innovations in veterinary medicines and advancement in technology, bovine respiratory disease is the leading cause to impact negatively on both the dairy and beef industries due to calf mortality, additional labor cost and treatment expenses. Moreover, bovine respiratory disease affects adversely on reproductive performance, growth and longevity of cattle. Hence, prevention and treatment of bovine respiratory disease have become important to decrease the impact on animal production and the beef industry. Therefore, the bovine respiratory disease treatment market is anticipated to witness significant growth in terms of revenue during the forecast period.
Request Brochure for Report –
Bovine Respiratory Disease Treatment Market: Snapshot
Lately, there is surge in the demand for beef meat as human population is increasingly relying on beef to meet their protein requirement. However, consumption of beef meat sourced from cattle with bovine respiratory diseases can severely impact the health of human population.
Meanwhile, bovine respiratory disease occurs due to multiple factors. Some of the factors include- shipping, weaning, weather, nutrition, mixing cattle among multiple sources, and respiratory viruses (BRSV, IBR, PI3, and BVD). Usually, the disease occurs frequently in the beef of calves between 70-170 days old, and it is communicable in nature.
The disease is captivating much attention in recent years as it is impacting the beef industry globally. In order to reduce the negative impact of bovine respiratory disease on entire beef industry, effective prevention measures and treatment is required.
Owing to the revenue being spent on bovine disease treatment globally, the bovine respiratory disease treatment market is projected to grow in coming years. As per the research report published by Transparency Market Research, the bovine respiratory disease treatment is likely to advance at a CAGR of 7.6% in between 2016 and 2024. The market value will reach to US$1543.9 mn by 2024.
Request for Analysis of COVID19 Impact on Bovine Respiratory Disease Treatment–
Pulmonary Care and Preventive Measures Fuelling Advancement in Treatment Procedures
There are multiple treatment options available for bovine respiratory diseases around the globe. Also, research is going on for the advanced treatment of bovine respiratory disease. This factor is most likely to contribute to the stellar growth of global bovine respiratory disease treatment market.
On the other hand, over the counter medication may cause severe side effects on the affected cattle. As a result of this, the market may experience hindrance in the growth of bovine respiratory disease treatment market. However, ongoing change in pattern the cattle care along with emphasis on pulmonary carry is most likely to fuel the expansion of global bovine respiratory disease treatment market.
Inclination Towards Consumption of Meat Demanding Better Treatment Options
North America has major share in the growth of global bovine respiratory disease treatment market, wherein the U.S. contributes 90% alone. The bovine respiratory disease treatment market is expanding because of increasing in-house production as well as excess consumption of bovine meat in the region. Also, the U.S. is also into the export business of bovine meat.
In spite of huge number of players in the bovine respiratory disease treatment market, the business landscape is a consolidated one. As a result, there is a high degree of competition in the market. Some of the prominent players in the bovine respiratory disease treatment market space are- Merck & Co., Bayer AG, Boehringer Ingelheim GmbH, Virbac Group, Elanco, Bimeda Animal Health, Zoetis Services LLC, Merial, Vetoquinol, and Ceva.
Buy Bovine Respiratory Disease Treatment Report –
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453